How would you like to attend The 5th International Trials Methodology Conference in Brighton, UK 6th to 9thOctober 2019?
To celebrate the collaboration between The Global Health Network and the new MRC/NIHR Trials Methodology Research Partnership, the Global Health Methodology Research Member Hub is excited to announce a competition inviting staff working in trials in low and middle-income countries to propose a trial methodology research study with a chance to win a funded attendance to this upcoming conference.
This competition is open to anyone working in a clinical trial role including; investigator, trial coordinator, statistician, data manager, research nurse, pharmacist and trial laboratory scientist.
The winner would have the unique opportunity to meet other researchers and discuss the current issues within trials and trials methodology. The event will showcase the very latest in trials methodology research and offer plenty of valuable opportunities for networking. The Conference will also mark 10 years since the Network of Hubs for Trials Methodology Research began in 2009.
For more information or to enter visit:
https://globalresearchmethods.tghn.org/articles/competition-win-funded-attendance-5th-international-trials-methodology-conference-brighton-uk/
The competition closes midnight (GMT+1) 31 July 2019
Read moreHere is an exciting opportunity to showcase the groundbreaking research, advocacy and frontline health provision that is taking place at the South African Medical Research Council and in your networks.
The 2019 REACH Awards will be recognizing stories of unsung achievement in disease elimination (Malaria, Tuberculosis, NTDs, and more) and raise awareness of the role of game-changing innovators within the larger global health community. Prominent leaders from across global health disciplines will judge the awards, including:
· Professor Baron Peter Piot, Director of the London School of Hygiene & Tropical Medicine
· Dr. Chris Elias, President of Global Development Division, Bill & Melinda Gates Foundation
· Dr. Maha Barakat, Executive Chair of the Roll Back Malaria Partnership
The winners will receive an undisclosed monetary prize, media visibility and the opportunity to come to Abu Dhabi’s Reaching the Last Mile Forum in November to receive the awards in front of high level global health leaders such as Bill Gates and Dr. Tedros.
About the 2019 REACH Awards
The REACH Awards uniquely honor unsung heroes working in the field of disease elimination who have demonstrated extraordinary leadership and commitment. Categories include:
· The Unsung Hero Award honors an extraordinary individual who has played a transformative, frontline role in the field of disease elimination, and has been under-recognized for his or her efforts.
· The Game-changing Innovator Award recognizes an individual who has developed and implemented a creative technology or practice in support of disease elimination.
· The Rising Champion Award celebrates an individual who is championing a cause related to disease elimination.
Nominations will remain open until July 12.
The Awards will be presented at the biennial Reaching the Last Mile Forum in November in front government officials, bilateral and multilateral aid leaders, global health experts, and industry leaders.
Read more
Abstract submissions for TBScience, the pre-conference to the 50th Union World Conference on Lung Health are now open.
TBScience is entirely devoted to basic and translational TB research. All aspects of TB prevention, diagnosis and treatment research, as well as basic science research, particularly new, innovative and significant findings are welcomed for submission.
Abstract submissions, either oral or poster presentations, should be aligned with one of these four session themes:
Submissions are open until 22 July 2019.
Read moreBase Pair has been collaborating with Dr. Misaki Wayengera of Makerere (TMA2015CDF1545) University in Uganda to explore aptamers for the development of simpler, more sensitive assays for the diagnosis of Ebolavirus.
Ebolavirus is a filovirus that causes severe hemorrhagic fever with a high rate of mortality. Believed to originate with the fruit bat, the virus can be transferred from infected animals and insects and also through the transfer of blood, mucus, or interaction with infected materials. On August 1, 2018, the Ministry of Health of the Democratic Republic of the Congo in Africa declared a new outbreak of Ebola Virus Disease (EVD) in the North Kivu Province. As of June 9, 2019, there have been 1,968 confirmed cases and 1,296 confirmed deaths. An experimental vaccine is being administered and a clinical trial for a new therapeutic is underway.
GP1 glycoprotein appears as spikes on the surface of the Ebolavirus virion. The glycoprotein is a heterodimer consisting of a GP1 and GP2 subunit. The glycoprotein forms a trimer consisting of three heterodimers on the virion surface. The GP1 subunit is involved in attachment to host cells and includes a receptor-binding domain. The smaller GP2 subunit includes a fusion peptide, a transmembrane domain and a short cytoplasmic tail. Glycoprotein residues involved in host entry are highly conserved between Zaire, Sudan, Cote d’Ivoire and Reston species of Ebolavirus.
https://www.basepairbio.com/elasa-aptamer-based-elisa/
Read more